Item 2.02 Results of Operations and Financial Condition On August 3, 2026, Ainos, Inc. (the “Company”) reported its financial results for the quarter ended June 30, 2026. A copy of the press release issued by the Company in this connection is furnished herewith as Exhibit 99.1.…
Filed Aug 3, 2026Accepted Aug 3, 2026, 5:20 PM EDTCIK 1014763Accession 0001493152-26-035859
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 2.02Item 2.02 - Results of Operations
Item
2.02 Results of Operations and Financial Condition
On
August 3, 2026, Ainos, Inc. (the “Company”) reported its financial results for the quarter ended June 30, 2026. A copy of
the press release issued by the Company in this connection is furnished herewith as Exhibit 99.1.
The
information in this Item in this Current Report on Form 8-K and Exhibit 99.1 attached hereto are being furnished and shall not be deemed
“filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended or the Exchange Act, regardless of any general incorporation language in such filing.
Filed exhibits (1)
EX-99.1 (by filename) ex99-1.htm
EX-99.1
2
ex99-1.htm
EX-99.1
Exhibit 99.1
Ainos
Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics
Markets
Ainos,
Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) (“Ainos” or the “Company”) today announced results for the second quarter ended
June 30, 2026, and provided a business update on continued execution progress for AI Nose across semiconductor manufacturing, industrial
infrastructure, robotics, and healthcare-related environments.
Eddy
Tsai, Chairman, President and Chief Executive Officer, commented:
“We
believe AI is increasingly expanding beyond understanding text, images, and speech toward interpreting real-world environmental information.
This vision continues to guide Ainos’ commercialization strategy for AI Nose. We believe future semiconductor manufacturing, industrial
infrastructure, healthcare environments, and robotics applications will increasingly require intelligent environmental awareness, and
AI Nose continues to advance steadily toward that objective.”
“During
the first half of 2026, we continued executing our commercialization roadmap by expanding AI Nose deployments across semic…